I now have excellent content from the textbooks. Let me compile the comprehensive answer.
Phenylephrine in Obstetric (MD) Anaesthesia
"MD" in the context of regional anaesthesia typically refers to Maternal/Obstetric anaesthesia - specifically its use for spinal-induced hypotension during Caesarean section. Here is a full breakdown:
Why Spinal Anaesthesia Causes Hypotension
Spinal anaesthesia for Caesarean delivery causes sympathetic blockade, leading to arteriolar and venodilation. This results in:
- Reduction in SVR and venous return
- Maternal hypotension (SBP fall >20% from baseline or <100 mmHg)
- Reduced uteroplacental perfusion, risking fetal acidosis and neonatal depression
The gravid uterus compounds this by causing aortocaval compression - left uterine displacement is always applied.
Phenylephrine: The Vasopressor of Choice
Mechanism: Pure selective alpha-1 adrenergic agonist. No direct beta activity. Raises blood pressure purely through peripheral vasoconstriction (increases SVR).
Why phenylephrine over ephedrine?
Historically, ephedrine (mixed alpha and beta stimulator) was used, but it:
- Crosses the placenta readily
- Stimulates fetal beta receptors, increasing fetal metabolic rate
- Causes higher rates of fetal acidosis (lower umbilical artery pH)
Phenylephrine:
- Has less placental transfer
- Results in less fetal acidosis - favourable fetal acid-base profile
- Is now the vasopressor of choice for treating post-spinal hypotension in obstetrics
As Miller's Anesthesia states: "Prophylactic or therapeutic phenylephrine in boluses or as an infusion is not only effective in reducing hypotension, but also has less transfer to the fetus and results in less fetal acidosis than ephedrine." (Miller's Anesthesia, 10e)
Dosing Regimens
1. Prophylactic Infusion (Preferred)
The International Consensus Statement (2018) and multiple systematic reviews recommend a prophylactic phenylephrine infusion combined with IV crystalloid co-loading and left lateral uterine displacement.
- Starting rate: typically 25-100 mcg/min (0.25-1 mcg/kg/min), titrated to blood pressure
- A systematic review found prophylactic infusion vs placebo significantly reduced:
- Risk of hypotension (RR 0.36; 95% CI, 0.18-0.73)
- Nausea and vomiting (RR 0.39; 95% CI, 0.17-0.91)
2. Rescue Bolus Dosing
- 50-100 mcg IV bolus for acute hypotension episodes
- Can be repeated as needed
- Variable-rate infusion + rescue boluses strategy is widely used
3. Combined Strategy
Variable-rate phenylephrine infusion with rescue boluses available is the current best practice - reduces the number of physician interventions for hypotension management.
Key Side Effect: Reflex Bradycardia
Because phenylephrine has no beta activity, the rise in BP triggers a baroreceptor-mediated reflex bradycardia:
- Heart rate decrease and decreased cardiac output are common
- This is usually well tolerated, but monitor HR
This is why norepinephrine (alpha + beta1) is gaining interest as an alternative:
- Norepinephrine maintains similar BP control
- Associated with greater heart rate and cardiac output compared to phenylephrine
- Emerging evidence supports its use, though phenylephrine remains the current standard
Practical Protocol Summary
| Step | Action |
|---|
| Position | Left uterine displacement (15-30 degrees) |
| Pre-loading | IV crystalloid co-load at time of spinal |
| Prophylaxis | Phenylephrine infusion ~25-100 mcg/min, start with spinal |
| Rescue bolus | 50-100 mcg IV for SBP <80-100 mmHg |
| Monitor | HR - if bradycardia develops, reduce or stop infusion |
| If bradycardia + hypotension | Use ephedrine (beta activity) or atropine |
| Norepinephrine | Alternative, especially if bradycardia is persistent |
Special Considerations
- Cardiac disease in pregnancy: Phenylephrine's increase in SVR and decrease in CO may not be well tolerated in some cardiac lesions (e.g., regurgitant lesions may benefit; stenotic lesions with fixed output require careful titration)
- Pre-eclampsia: Recent meta-analyses (PMID 39437476, 2024) suggest norepinephrine may be preferable to phenylephrine in pre-eclamptic patients - evidence is still evolving
- Bradycardia management: If maternal HR falls below 55-60 bpm, reduce infusion rate; atropine 0.6 mg IV or ephedrine can be used
- Fetal outcome: Despite causing reflex bradycardia and lower CO, umbilical artery pH and neonatal Apgar scores are better with phenylephrine than ephedrine
Recent Evidence Updates
Three recent systematic reviews (2024-2025) are relevant:
- PMID 39437476 - Norepinephrine vs phenylephrine in pre-eclampsia: norepinephrine shows comparable or better outcomes in pre-eclamptic patients
- PMID 39715512 - Phenylephrine bolus vs infusion: infusion regimens result in better maternal haemodynamic stability and fetal outcomes
- PMID 40522505 - Network meta-analysis 2025: norepinephrine and phenylephrine are comparable; norepinephrine has higher HR/CO
Summary: Phenylephrine infusion (25-100 mcg/min, titrated) + rescue boluses (50-100 mcg) is the current standard of care for prevention and treatment of spinal hypotension during Caesarean section. It is preferred over ephedrine for better fetal acid-base outcomes. Its main limitation is reflex bradycardia with reduced cardiac output, which makes norepinephrine an increasingly attractive alternative.
Sources: Miller's Anesthesia 10e; Barash Clinical Anesthesia 9e; Tintinalli's Emergency Medicine; International Consensus Statement (Anaesthesia, 2018)